Ikarian Capital
GOSS icon

Ikarian Capital’s Gossamer Bio GOSS Stock Holding History

Ikarian Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-76
Closed -$7.69K – 148
2023
Q1 		$7.69K Hold
76
– – ﹤0.01% 117
2022
Q4 		$13.2K Sell
76
-7,554
-99% -$4.98M ﹤0.01% 83
2022
Q3 		$7.31M Sell
7,630
-4,875
-39% -$4.84M 1.46% 23
2022
Q2 		$8.37M Buy
12,505
+2,814
+29% +$1.74M 1.53% 22
2022
Q1 		$6.73M Sell
9,691
-4,896
-34% -$3.78M 0.89% 32
2021
Q4 		$13.2M Sell
14,587
-2,312
-14% -$2.2M 1.97% 13
2021
Q3 		$17M Buy
16,899
+3,794
+29% +$2.79M 1.2% 16
2021
Q2 		$8.51M Hold
13,105
– – 0.69% 42
2021
Q1 		$9.7M Hold
13,105
– – 0.33% 71
2020
Q4 		$10.1M Buy
13,105
+5,824
+80% +$4.59M 0.45% 52
2020
Q3 		$7.23M Sell
7,281
-1,519
-17% -$1.61M 0.52% 46
2020
Q2 		$9.15M Buy
+8,800
New +$8.85M 0.73% 46

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Samsara BioCapital
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Ikarian Capital's GOSS Position: Q2 2023 in Review

Ikarian Capital sold out of Gossamer Bio (GOSS) in Q2 2023, closing a stake of 76 shares — an estimated $7.69K sold.

Ikarian Capital first reported a position in GOSS in Q2 2020 and held it in 12 quarters. The position peaked at $17M in Q3 2021. 98 funds tracked by Wall St. Rank hold GOSS as of Q2 2023.

  • Ikarian Capital reported no remaining Gossamer Bio position as of Q2 2023 after selling out during the quarter.
  • Ikarian Capital sold 76 Gossamer Bio shares in Q2 2023, an estimated $7.69K.
  • Ikarian Capital first reported a position in Gossamer Bio in Q2 2020 and held it in 12 quarters.
  • Ikarian Capital's Gossamer Bio position peaked at $17M in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2023.

Based on Ikarian Capital's 13F filing for Q2 2023, filed 14 Aug 2023.